Also trades as: 600196.SS (SHH) · $vol 96M · 2196.HK (HKSE) · $vol 9M

$2.45

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 72 · $6.5B mcap · 941M float · 0.0000% daily turnover · Short 57% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$40.4B -1.6% ▼

5Y CAGR: +5.9%

Gross Profit

$20.2B +2.3% ▲

5Y CAGR: +3.6%

Operating Income

$2.5B -40.3% ▼

5Y CAGR: -11.7%

Net Income

$3.3B +18.5% ▲

5Y CAGR: -2.2%

EPS (Diluted)

$1.26 +21.2% ▲

5Y CAGR: -2.5%

EBITDA

$6.2B -28.4% ▼

5Y CAGR: -3.3%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$39.0B	$44.0B	$41.4B	$41.1B	$40.4B
YoY Growth	+28.7%	+12.7%	-5.8%	-0.8%	-1.6%
Cost of Revenue	$20.2B	$23.2B	$21.6B	$21.4B	$20.3B
Gross Profit	$18.8B	$20.8B	$19.8B	$19.7B	$20.2B
Gross Margin	48.1%	47.3%	47.8%	48.0%	49.9%
R&D Expenses	$3.8B	$4.3B	$4.3B	$3.6B	$3.9B
SG&A Expenses	$9.9B	$10.2B	$7.4B	$6.5B	$13.7B
Operating Expenses	$16.1B	$17.1B	$16.5B	$15.5B	$17.6B
Operating Income	$6.3B	$8.3B	$3.3B	$4.2B	$2.5B
Operating Margin	16.2%	18.9%	8.0%	10.3%	6.3%
Interest Expense	$823M	$964M	$1.3B	$1.4B	$1.2B
Income Before Tax	$6.1B	$4.6B	$3.3B	$4.2B	$5.0B
Tax Expense	$1.1B	$627M	$370M	$657M	$842M
Net Income	$4.7B	$3.7B	$2.4B	$2.8B	$3.3B
Net Margin	12.1%	8.5%	5.8%	6.7%	8.1%
EPS (Diluted)	$1.85	$1.43	$0.89	$1.04	$1.26
EBITDA	$8.8B	$7.9B	$5.6B	$8.6B	$6.2B
Shares Outstanding	2.56B	2.61B	2.68B	2.66B	2.65B

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$10.2B	$10.4B	$10.2B	$9.4B	$10.1B	$21.7B	$10.1B	$20.1B
Cost of Revenue	$5.7B	$5.4B	$5.5B	$4.9B	$5.2B	$10.5B	$5.1B	$10.1B
Gross Profit	$4.5B	$5.0B	$4.7B	$4.5B	$4.9B	$11.2B	$5.0B	$10.0B
Gross Margin	44.0%	48.1%	46.1%	47.8%	48.5%	51.6%	49.7%	49.5%
R&D Expenses	$937M	$786M	$996M	$737M	$979M	$2.3B	$897M	$2.1B
SG&A Expenses	$2.9B	$6.6B	-$3.3B	$3.1B	-$56M	-$2.5B	$3.3B	$3.4B
Operating Expenses	$3.8B	$3.8B	$3.5B	$3.1B	$3.5B	$9.8B	$3.6B	$8.7B
Operating Income	$680M	$1.2B	$1.1B	$1.4B	$1.4B	$1.4B	$1.4B	$1.2B
Operating Margin	6.6%	11.3%	11.2%	14.4%	13.9%	6.3%	13.7%	6.2%
Interest Expense	$361M	$358M	$364M	$330M	$323M	$602M	$297M	$599M
Income Before Tax	$402M	$1.1B	$1.1B	$1.3B	$1.4B	$2.4B	$1.4B	$2.6B
Tax Expense	$149M	$172M	$104M	$406M	$212M	$242M	$278M	$432M
Net Income	$615M	$786M	$759M	$765M	$937M	$1.6B	$871M	$1.7B
Net Margin	6.0%	7.5%	7.5%	8.1%	9.3%	7.6%	8.6%	8.4%
EPS (Diluted)	$0.23	$0.30	$0.29	$0.29	$0.35	$0.62	$0.33	$0.65
EBITDA	$1.5B	$1.8B	$1.5B	$1.7B	$1.7B	$3.4B	$1.6B	$3.1B
Shares Outstanding	2.67B	2.66B	2.66B	2.66B	2.66B	2.64B	2.64B	2.64B

SFOSF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet